Topical Application of 5-HT Antibodies Reduces Edema and Cell Changes Following Trauma of the Rat Spinal Cord

Acta Neurochirurgica, Supplement

Volumn 1997, Issue 70, 1997, Pages 155-158

  Sharma, H S ^a,b   Westman, J ^a   Nyberg, F ^b  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

5 HT; Blood spinal cord barrier; Cell changes; Edema; Immunohistochemistry; Spinal cord injury

Indexed keywords

MONOCLONAL ANTIBODY; SEROTONIN;

ANIMAL; ARTICLE; CAPILLARY PERMEABILITY; EDEMA; IMMUNOLOGY; MALE; PATHOLOGY; RAT; SPINAL CORD; SPINAL CORD INJURY; TOPICAL DRUG ADMINISTRATION; VASCULARIZATION; WISTAR RAT;

ADMINISTRATION, TOPICAL; ANIMALS; ANTIBODIES, MONOCLONAL; CAPILLARY PERMEABILITY; EDEMA; MALE; RATS; RATS, WISTAR; SEROTONIN; SPINAL CORD; SPINAL CORD INJURIES;

EID: 0031305205     PISSN: 00651419     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-6837-0_47     Document Type: Article

References (18)

1. Chaouloff F (1993) Physiopharmacological interactions between stress hormones and central serotonergic systems. Brain Res Rev 18: 1-32
2. Essman W (1978) Serotonin in health and diseases, vol I-V. Spectrum, New York
3. Faden AI (1993) Experimental neurobiology of central nervous system trauma. Crit Rev Neurobiol 7: 175-186
4. Frelinger AL 3rd, Cohen I, Plow EF, Smith MA, Roberts J, Lam SC-T, Ginsberg MH (1990) Selective inhibition of integrin function by antibodies specific for ligand-occupied receptor conformers. J Biol Chem 265: 6346-6352
5. Garcia KC, Ronco PM, Verroust PJ, Brünger AT, Amzel LM (1992) Three-dimensional structure of an angiotensin II-fab complex at 3A: hormone recognition by an anti-idiotypic antibody. Science 257: 502-507
6. Klein R, Bansch M, Berg PA (1992) Clinical relevance of antibodies against serotonin and gangliosides in patients with primary fibromyalgia syndrome. Psychoneuroendocrinology 17: 593-598
7. Prammer KV, Boyer J, Ugen K, Shattil SJ, Kieber-Emmons T (1994) Bioactive Arg-Gly-Asp conformations in anti-integrin GPIIb-IIIa antibodies. Receptor 4: 93-108
8. Salzman SK, Puniak MA, Liu ZJ, Maitland-Heriot RP, Freeman GM, Agresta CA (1991) The serotonin antagonist mianserin improves functional recovery following experimental spinal trauma. Ann Neurol 30: 533-541
9. Schwab ME, Bartholdi D (1996) Degeneration and regeneration of axons in the lesioned spinal cord. Physiol Rev 76: 319-370
10. Shapiro S, Kubek M, Siemers E, Daly E, Callahan J, Putty T (1995) Quantification of thyrotrophin-releasing hormone and serotonin content changes following graded spinal cord injury. J Surg Res 59: 393-398
11. Sharma HS, Olsson Y (1990) Edema formation and cellular alterations following spinal cord injury in rat and their modification with p-chlorophenylalanine. Acta Neuropathol (Berlin) 79: 604-610
12. Sharma HS, Olsson Y, Dey PK (1990) Early accumulation of serotonin in rat spinal cord subjected to traumatic injury. Relation to edema and blood flow changes. Neuroscience 36: 725-730
13. Sharma HS, Olsson Y, Nyberg F, Dey PK (1993) Prostaglandins modulate alterations of microvascular permeability, blood flow, edema and serotonin levels following spinal cord injury: and experimental study in the rat. Neuroscience 57: 443-449
14. Sharma HS, Olsson Y, Dey PK (1995) Serotonin as a mediator of increased microvascular permeability of the brain and spinal cord. Experimental observations in anaesthetised rats and mice. In: Greenwood J, Begley D, Segal M, Lightman S (eds) New concepts of a blood-brain barrier. Plenum, New York, pp 75-80
15. Sharma HS, Olsson Y, Nyberg F (1995) Influence of dynorphin-A antibodies on the formation of edema and cell changes in spinal cord trauma. In: Nyberg F, Sharma HS, Wissenfeld-Halin Z (eds) Prog Brain Res 104. Elsevier, Amsterdam, pp 401-416
16. Sharma HS, Westman J, Olsson Y, Alm P (1996) Involvement of nitric oxide in acute spinal cord injury: an immunocytochemical study using light and electron microscopy in the rat. Neurosci Res 24: 373-384
17. Shattil SJ, Weisel JW, Kieber-Emmons T (1992) Use of monoclonal antibodies to study the interaction between an integrin adhesion receptor,. GP IIb-IIIa, and its physiological ligand, fibrinogen. Immunomethods 1: 53-63
18. Taub R, Gould R J, Garsky VM, Ciccarine TM, Hoxie J, Friedman PA, Shattil SJ (1989) A monoclonal antibody against platelet fibrinogen receptor contains a sequence that mimics a receptor recognition domain in fibrinogen. J Biol Chem 264: 259-265